Möbius Labsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2024-10-18
Share capital
10 000,00 PLN
Activity description

Möbius Lab develops technologies in biophotonics, longevity and wellness, including an NAD+ product based on its photokinetic technology. The company also develops light-based technologies to support seeds and reduce fertilizer use, as well as diagnostics and therapy based on the body’s bioelectric signatures.

Registered address
ul. Stroma 6, 43-450 Ustroń, Poland
Website
mobiuslab.plWebsite active
Phone

Financials

Revenue history

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 875.42MedianUSD 38.54kAverageUSD 2.32m
Net profit
This companyUSD -1.98kMedianUSD -1.56kAverageUSD -88.44k
Operating costs
This companyUSD 2.86kMedianUSD 56.03kAverageUSD 2.29m
Assets
This companyUSD 26.29kMedianUSD 119.99kAverageUSD 2.73m

Bank accounts

Registered as a VAT taxpayer on 2025-09-01. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Anna Ewa Flasza – Vice President of the Management Board
Jakub Roman Jędrzejewicz – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will independently on behalf of the company, both in the case of a one-person management board and in the case of a multi-member management board.

Ownership

OwnerSharesShare valueStake
Anna Ewa Flasza (68)
34$918.4229.0598%
Jakub Roman Jędrzejewicz (45)
50$1,350.6242.735%
Igor Ogorodnyk (59)
33$891.4128.2051%

Beneficial owners

Person

Competitors

Name
Microbiota Medsp. z o.o.
MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o.
Poltisssp. z o.o.
Refolditsp. z o.o.
Neobiolabsp. z o.o.
NanotheaS.A.

FAQ

Last updated: 2026-06-30